adult acute myeloblastic leukemia without maturation (M1)
Showing 1 - 25 of >10,000
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- Sirolimus
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 2, 2023
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- trebananib
- +3 more
-
Buffalo, New York
- +1 more
Sep 8, 2022
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,
Terminated
- Adult Acute Basophilic Leukemia
- +16 more
- eltrombopag olamine
- standard follow-up care
-
Atlanta, Georgia
- +1 more
Jul 20, 2022
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult
Active, not recruiting
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +18 more
- eltrombopag olamine
-
Cleveland, OhioCase Comprehensive Cancer Center
Nov 29, 2021
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- fludarabine phosphate
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 20, 2021
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- choline magnesium trisalicylate
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 20, 2021
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in United
Completed
- Adult Acute Basophilic Leukemia
- +16 more
-
Little Rock, Arkansas
- +53 more
Jan 13, 2022
Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)
Not yet recruiting
- Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
- (no location specified)
Feb 27, 2023
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- standard follow-up care
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jul 29, 2020
Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
-
Nantes, FranceCHU of Nantes
Dec 16, 2022
Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
-
Nantes, FranceCHU de Nantes
Jan 24, 2023
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- azacitidine
- +3 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
May 13, 2020
Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
- Ivosidenib Oral Tablet
- Azacitidine
-
Vienna, Austria
- +3 more
Jun 8, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Laboratory Biomarker Analysis
- +3 more
-
Chicago, Illinois
- +2 more
Jan 12, 2023
Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level
Not yet recruiting
- Relapsed Adult AML
- Refractory AML
- Navitoclax Dose Level -1
- +10 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023
Leukemia, Myeloid, Acute, MDS Trial in Japan, Korea, Republic of, Taiwan (Pevonedistat 25 mg/m^2, Pevonedistat 44 mg/m^2,
Completed
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Pevonedistat 25 mg/m^2
- +4 more
-
Maebashi City, Japan
- +8 more
Jun 23, 2022
Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)
Recruiting
- Acute Myeloid Leukemia, Adult
- cladribine + homoharringtonine + cytarabine
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Completed
- Acute Myeloid Leukemia
- +19 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Lewes, Delaware
- +16 more
Aug 3, 2022
DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- +8 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Jul 12, 2022
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)
Not yet recruiting
- Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
-
Hefei, Anhui, China
- +7 more
Jun 27, 2023
Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Miami, FloridaUniversity of Miami
Dec 22, 2022
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in
Recruiting
- Acute Biphenotypic Leukemia
- +13 more
- Cladribine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2023
Patients With Acute Leukemia Infected by COVID-19
Completed
- Acute Myeloblastic Leukemia
- +2 more
-
Amiens, France
- +26 more
Jul 26, 2022